šŸŽ“ Patient Eligibility

Inclusion Criteria:

  • Adult women (age 18–65)
  • Classic symptoms: dysuria, urinary frequency, urgency, suprapubic discomfort
  • No vaginal discharge or irritation
  • No fever (>99.9°F/37.7°C), flank pain, or systemic symptoms

Exclusion Criteria:

  • Pregnant women
  • Men
  • Immunocompromised patients
  • Known urologic abnormalities (e.g., neurogenic bladder, stones)
  • Indwelling catheters
  • Recent urologic procedure
  • Symptoms suggestive of pyelonephritis (fever, chills, flank pain, nausea/vomiting)
  • Recurrent UTI (>3/year)
  • Recent antibiotic use (within 4 weeks)
  • Allergy to first-line antibiotics

Ā 

āŒ› History Taking (via Telemedicine)

  • Onset, duration, and severity of symptoms
  • Presence of dysuria, frequency, urgency, hematuria, suprapubic pain
  • Absence of vaginal symptoms (discharge, irritation)
  • Fever, chills, back/flank pain, nausea/vomiting
  • Sexual history, contraception, last menstrual period (if relevant)
  • Past UTI history, prior antibiotic use, allergies
  • Comorbidities (diabetes, immunosuppression, renal disease)
  • Pregnancy status

Ā 

āœšŸ¼ Assessment

  • If classic lower urinary tract symptoms are present and no exclusion criteria, proceed with empiric treatment.
  • If symptoms are atypical or exclusion criteria are met, recommend in-person evaluation and/or urinalysis/culture.

Ā 

šŸ’¼ Management

First-Line Empiric Therapy (Uncomplicated Cystitis):

  • Nitrofurantoin 100 mg PO BID x 5 days (avoid if CrCl <30 mL/min)
  • Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg PO BID x 3 days (if local resistance <20% and no allergy)
  • Fosfomycin 3 g PO single dose (less preferred due to lower efficacy)

Alternatives (if above contraindicated):

  • Beta-lactams (e.g., amoxicillin-clavulanate, cefdinir) x 5–7 days (less preferred due to lower efficacy)

Symptomatic Relief:

  • Phenazopyridine 200 mg PO TID x 2 days (optional, for dysuria)

Ā 

🚩 Follow-Up and Red Flags

  • Advise patient to follow up if:
    • Symptoms persist >48–72 hours after starting antibiotics
    • Develops fever, flank pain, nausea/vomiting
    • Allergic reaction to medication
  • If symptoms worsen or pyelonephritis suspected, refer for in-person evaluation and possible urine culture.

Ā 

šŸ“„ Documentation

  • Document all history, assessment, rationale for telemedicine management, antibiotic choice, and patient education.
  • If UTI is recurrent or complicated, recommend urine culture and/or referral.

Ā 

✨ Special Considerations

  • For patients with recurrent UTIs, consider further workup and urology referral.
  • For postmenopausal women, consider vaginal estrogen if recurrent UTIs.

Ā 

āš ļø Note: This protocol is for uncomplicated cystitis in non-pregnant adult women.

Ā